TREADS: Target Research for Anti-epileptic Drugs Using Data Science

Area of Science:

• Neurology
• Bioinformatics
• Pharmacology

Background:

• Epilepsy is a neurological disorder with diverse classifications and numerous associated genes, proteins, and microRNAs.
• Currently, epilepsy-associated data is fragmented across various public repositories, hindering comprehensive research.
• Existing anti-epileptic drugs (AEDs) target specific proteins, but a unified resource for exploring these targets is lacking.

Purpose of the Study:

• To develop a centralized platform for epilepsy research data integration.
• To provide tools for analyzing epilepsy-associated proteins and predicting drug-target interactions.
• To facilitate the study of anti-epileptic drug (AED) targets within the epilepsy research community.

Main Methods:

• Utilized text mining to extract epilepsy-associated data from multiple biological sources.
• Curated and integrated extracted data into an in-house developed epilepsy database.
• Developed in-house machine learning models to predict protein druggability based on significant protein features.

Main Results:

• Epilepsy-associated data is now accessible via a web browser interface.
• The platform displays feature values for proteins of interest.
• Machine learning model results are presented as visualization plots for enhanced data interpretation.

Conclusions:

• TREADS (Epilepsy Research Platform) offers a unified database and machine learning tool for the epilepsy research community.
• The platform aims to streamline the study of anti-epileptic drug targets.
• TREADS provides a valuable resource for advancing epilepsy research and drug discovery.